BOSTON, July 14, 2022 (GLOBE NEWSWIRE) — Julythe AI-powered digital health platform that delights and engages users to power their own health while offering their healthcare providers insights from episodic health data, announced the formation of an advisory board filled with digital health luminaries.
Launched more than a year ago, juli helps people manage complex chronic conditions by aggregating and analyzing data from EMRs, smartphones, wearables, the environment and patient-reported data. By applying AI to these disparate data sources, juli identifies never-before-seen correlations and encourages micro-behavioral changes in users that can help alleviate conditions such as depression, bipolar disorder, asthma, migraines and chronic pain.
juli welcomes founding advisory board members representing the broad range of digital health expertise from prominent organizations across the US. Advisory board members will help the company refine its business and clinical development strategies, build strategic relationships with customers and partners, and attract new investment.
Joe KvedarMD – A professor at Harvard Medical School and a pioneer in digital health, Kvedar is also editor-in-chief of Nature’s npj Digital Medicine and just completed his term as board chair of the American Telemedicine Association.
Kristen Valdez – Founder and CEO of b.well Connected Health, the digital transformation platform, and former CEO of UnitedHealthcare, Valdes has over 20 years of experience making health data more easily compatible with less friction for health plan members and users, including as a member of the board of Alliance KARIN.
Laurie McGraw – Board Director of NASDAQ Companies, Venture & Startup Advisor, and Healthcare Capital Champion. McGraw most recently served as a senior vice president at the American Medical Association and was previously president of Allscripts.
Rajiv Kumar, Ph.D – A digital health entrepreneur, physician and angel investor, Dr. Kumar is the former president and chief medical officer of Virgin Pulse.
“We are honored to bring on a stellar advisory board of heavy hitters in the digital health industry,” said juli CEO and co-founder Bettina Hein, a serial entrepreneur who has built successful technology companies in Europe and the U.S. “All of our new advisors are highly accomplished luminaries in the field and are already proving invaluable as we enter the next phase of the company’s growth.”
“I am excited to be part of such an innovative and talented team poised to change the way healthcare is delivered,” said Dr. Kvedar.
“People with chronic illnesses are desperate for a solution that will help them take control of their health and generate new insights for healing,” Valdes said. “Juli is uniquely designed to achieve this goal by allowing users to integrate the health data we all produce every day, while avoiding the limitations of point solutions that address each disease individually without looking at the whole patient.”
“I am excited to help the juli team focus on the unmet need for people to manage their chronic conditions with dignity,” said McGraw. “They have an excellent product with robust AI that leverages the convergence of digital health tools, and they have a real opportunity to help bend the curve in healthcare.”
Dr Kumar added: “There are few truly consumer digital health solutions aimed at the enterprise, and juli is one of them. Today’s digital health apps have to compete for mindshare with TikTok, not WebMD, and juli rises to the challenge.”
Since launching a year ago, juli has raised $3.8 million in seed funding and won recognition from global networks of innovators including MassChallenge HealthTech. Approximately 20,000 patients have used the juli app to track data on chronic, debilitating conditions and comorbidities. juli was selected by the US Department of Health and Human Services as one of 15 digital health startups to join the 2022 PandemicX Accelerator cohort and is one of only 10 global companies selected in the Emerge program of the SoftBank Vision Fund.
juli is powered by AI a next-generation chronic disease management platform for multifactorial and comorbid conditions, currently encompassing asthma, migraine, chronic pain, depression and bipolar disorder.
Patients and care teams using juli can easily track their condition, understand the triggers and get referrals for how to get better or avoid the next episode.
Insurers, employers, providers and health systems can see how their population is doing and allocate resources to help the right person at the right time. This saves significant costs and empowers patients to take an active role in managing their condition.
For more information visit https://www.juli.co/.
The photos accompanying this announcement are available at: